UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.412-420

2013

Volltextzugriff (PDF)

Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

Respiratory research, 2016-01, Vol.17 (11), p.10-10, Article 10

2016

Volltextzugriff (PDF)

Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis

Scientific reports, 2023-11, Vol.13 (1), p.19649-19649, Article 19649

2023

Volltextzugriff (PDF)

Voice and swallowing after total laryngectomy

Acta oto-laryngologica, 2018-02, Vol.138 (2), p.170-174

2018

Volltextzugriff (PDF)

A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy

Allergy, asthma, and clinical immunology, 2020-04, Vol.16 (1), p.31-31, Article 31

2020

Volltextzugriff (PDF)

HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study

Allergy, asthma, and clinical immunology, 2021-06, Vol.17 (1), p.1-55, Article 55

2021

Volltextzugriff (PDF)

Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis

Respirology (Carlton, Vic.), 2011-02, Vol.16 (2), p.300-307

2011

Volltextzugriff (PDF)

Increased Plasma Levels of Serine Proteinase Inhibitors in Lung Cancer Patients

Anticancer research, 2004-01, Vol.24 (1), p.241-247

2004

Volltextzugriff (PDF)

High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase

Allergy (Copenhagen), 2022-03, Vol.77 (3), p.883-896

2022

Volltextzugriff (PDF)

Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial

Journal of allergy and clinical immunology, 2018-10, Vol.142 (4), p.1338-1341.e9

2018

Volltextzugriff (PDF)

α1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro

Cancer cell international, 2004-11, Vol.4 (1), p.7-7

2004

Volltextzugriff (PDF)

The Pharyngoesophageal Segment After Total Laryngectomy

Annals of otology, rhinology & laryngology, 2017-02, Vol.126 (2), p.138-145

2017

Volltextzugriff (PDF)

Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe α1-antitrypsin deficiency

BMC pulmonary medicine, 2007-01, Vol.7 (1), p.1-1, Article 1

2007

Volltextzugriff (PDF)

Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor

Clinical and experimental allergy, 2012-04, Vol.42 (4), p.590-596

2012

Volltextzugriff (PDF)

Novel strategies for the treatment of grass pollen-induced allergic rhinitis

Expert opinion on biological therapy, 2016-09, Vol.16 (9), p.1143-1150

2016

Volltextzugriff (PDF)

Prolastin, a pharmaceutical preparation of purified human α1-antitrypsin, blocks endotoxin-mediated cytokine release

Respiratory research, 2005-01, Vol.6 (1), p.12-12, Article 12

2005

Volltextzugriff (PDF)

Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro

Cancer cell international, 2003-08, Vol.3 (1), p.14-14, Article 14

2003

Volltextzugriff (PDF)

Treatment of cricopharyngeal dysfunction: a comparative pilot study

BMC research notes, 2015-07, Vol.8 (1), p.301-301, Article 301

2015

Volltextzugriff (PDF)

Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma

Respiratory medicine, 2007-09, Vol.101 (9), p.1947-1953

2007

Volltextzugriff (PDF)

Measured Adiposity in Relation to Head and Neck Cancer Risk in the European Prospective Investigation into Cancer and Nutrition

Cancer epidemiology, biomarkers & prevention, 2017-06, Vol.26 (6), p.895-904

2017

Volltextzugriff (PDF)

KUL fyller i kunskapsluckor

Läkartidningen, 2018, Vol.115 (30-32)

2018

Volltextzugriff (PDF)

Prolastin, a pharmaceutical preparation of purified human alpha 1-antitrypsin, blocks endotoxin-mediated cytokine release

Respiratory research, 2005, Vol.6 (1)

2005

Volltextzugriff (PDF)

Allergen-specific immunotherapy increases plasma gelsolin levels

American journal of rhinology & allergy, 2014-05, Vol.28 (3), p.e136-e140

2014

Volltextzugriff (PDF)

Intralymphatic Immunotherapy (ILIT) with both grass and birch allergen‐ a randomized controlled trial

Clinical and translational allergy, 2015-06, Vol.5 (1), p.P29-n/a

2015

Volltextzugriff (PDF)

Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa

Mediators of Inflammation, 2001-10, Vol.2001 (5), p.269-272

2001

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(48)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis

Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial

Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis

Voice and swallowing after total laryngectomy

A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy

HealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study

Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis

Increased Plasma Levels of Serine Proteinase Inhibitors in Lung Cancer Patients

High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase

Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial

α1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro

The Pharyngoesophageal Segment After Total Laryngectomy

Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe α1-antitrypsin deficiency

Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor

Novel strategies for the treatment of grass pollen-induced allergic rhinitis

Prolastin, a pharmaceutical preparation of purified human α1-antitrypsin, blocks endotoxin-mediated cytokine release

Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro

Treatment of cricopharyngeal dysfunction: a comparative pilot study

Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma

Measured Adiposity in Relation to Head and Neck Cancer Risk in the European Prospective Investigation into Cancer and Nutrition

KUL fyller i kunskapsluckor

Prolastin, a pharmaceutical preparation of purified human alpha 1-antitrypsin, blocks endotoxin-mediated cytokine release

Allergen-specific immunotherapy increases plasma gelsolin levels

Intralymphatic Immunotherapy (ILIT) with both grass and birch allergen‐ a randomized controlled trial

Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa

Suchergebnisse filtern